Evaluation of Effectiveness of Acupuncture on Quality of Life in Patients With Breast Cancer Receiving Chemotherapy
1 other identifier
interventional
140
1 country
1
Brief Summary
The aim of this trial is to investigate the effectiveness of acupuncture on quality of life in patients with breast cancer receiving chemotherapy compared to routine care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable breast-cancer
Started Oct 2012
Typical duration for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 7, 2012
CompletedFirst Posted
Study publicly available on registry
November 16, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedJuly 24, 2017
July 1, 2017
4.2 years
November 7, 2012
July 21, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)
6 month
Secondary Outcomes (1)
Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)
3 month
Other Outcomes (22)
Subscales of the Functional Assessment of Cancer Therapy - General (FACT-G): physical well-being, social/family well-being, emotional well-being, functional well-being
3 month
Subscales of the Functional Assessment of Cancer Therapy - General (FACT-G): physical well-being, social/family well-being, emotional well-being, functional well-being
6 month
Subscale for Breast Cancer of the Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)
3 month
- +19 more other outcomes
Study Arms (2)
Usual care + acupuncture
ACTIVE COMPARATORUsual care
ACTIVE COMPARATORInterventions
Patients of this group receive a semi-standardized acupuncture treatment over 6 month in addition to usual care
Eligibility Criteria
You may qualify if:
- diagnosed breast cancer (invasive, intraductal, hormone-sensitive and not hormone-sensitive, only locoregional metastases)
- current chemotherapy at Mammazentrum Hamburg with regimen FEC/DOC or EC/DOC
- willingness to receive acupuncture within the next 6 month if randomized in acupuncture group
- willingness to refrain from acupuncture within the next 6 month if randomized in control group
- informed consent
You may not qualify if:
- distant metastases
- blood coagulation disorder and/or current use of anticoagulants
- serious acute or chronic mental or physical disorders
- clinically relevant cardiac arrhythmia symptoms
- insufficient German language ability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mammazentrum Hamburg am Krankenhaus Jerusalem
Hamburg, 20357, Germany
Related Publications (2)
Stockigt DMB, Kirschbaum B, Carstensen DMM, Witt DMCM, Brinkhaus DMB. Prophylactic Acupuncture Treatment During Chemotherapy in Patients With Breast Cancer: Results of a Qualitative Study Nested in a Randomized Pragmatic Trial. Integr Cancer Ther. 2021 Jan-Dec;20:15347354211058207. doi: 10.1177/15347354211058207.
PMID: 34814766DERIVEDBrinkhaus B, Kirschbaum B, Stockigt B, Binting S, Roll S, Carstensen M, Witt CM. Prophylactic acupuncture treatment during chemotherapy with breast cancer: a randomized pragmatic trial with a retrospective nested qualitative study. Breast Cancer Res Treat. 2019 Dec;178(3):617-628. doi: 10.1007/s10549-019-05431-5. Epub 2019 Sep 13.
PMID: 31520284DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martin Carstensen, Prof. MD
Mammazentrum am Krankenhaus Jerusalem, Hamburg, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, MD
Study Record Dates
First Submitted
November 7, 2012
First Posted
November 16, 2012
Study Start
October 1, 2012
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
July 24, 2017
Record last verified: 2017-07